trending Market Intelligence /marketintelligence/en/news-insights/trending/Cz7K_AkO9zY2FzIT4jVi_w2 content esgSubNav
In This List

Sanofi nominates director to Regeneron Pharmaceuticals board

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Sanofi nominates director to Regeneron Pharmaceuticals board

Regeneron Pharmaceuticals Inc. added Tony Coles to its board.

The director was nominated by Sanofi, which owns 21.9% of the company, according to S&P Capital IQ data.

Coles is the chairman and CEO of Yumanity Therapeutics.